Prosecution Insights
Last updated: October 04, 2026

Uwm Research Foundation Inc.

Technology area: Biotechnology & Pharmaceuticals

2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Uwm Research Foundation Inc. has 1 pending office action currently in its portfolio. This matter is assigned to 1 distinct examiner. The busiest examiner for the company is HAVLIN, ROBERT H, who is responsible for 1 pending office action. With 0 distinct art units reported, the prosecution is focused entirely on the interaction with this specific examiner for the 1 pending application. The foundation can prioritize its strategy based on the individual feedback from HAVLIN, ROBERT H, as the data shows no other active examiners or art units involved in the current 1 pending office action.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (50%)
1
Medium (50%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (50%)
Multi-statute (no §101)1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
50% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
50% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HAVLIN, ROBERT H 1 51.5% +28.1%
CHEONG, CHEOM-GIL 1 64.2% +52.6%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18120799 PSEUDOMONAS STRAINS AND THEIR METABOLITES TO CONTROL CITRUS HUANGLONGBING AND RELATED DISEASES CHEONG, CHEOM-GIL —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18855496 DEUTERATED BENZODIAZEPINE ANALOGS AND METHODS OF USE IN TREATING CANCER HAVLIN, ROBERT H —
18120799 PSEUDOMONAS STRAINS AND THEIR METABOLITES TO CONTROL CITRUS HUANGLONGBING AND RELATED DISEASES CHEONG, CHEOM-GIL —

Top Art Units

Art UnitApps
1645 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18855496 DEUTERATED BENZODIAZEPINE ANALOGS AND METHODS OF USE IN TREATING CANCER HAVLIN, ROBERT H — §103 Non-Final OA — Pending Oct 09, 2024
18120799 PSEUDOMONAS STRAINS AND THEIR METABOLITES TO CONTROL CITRUS HUANGLONGBING AND RELATED DISEASES CHEONG, CHEOM-GIL 1645 §102§112Other Final Rejection — Pending Mar 13, 2023

Managing Uwm Research Foundation Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month